What Is a Molecular COVID Test and How Does It Work?

A molecular COVID test detects the genetic material (RNA) of the SARS-CoV-2 virus in a sample from your nose, throat, or saliva. It’s the most accurate type of COVID test available, with sensitivity above 90% and specificity reaching 100% in clinical studies. The most common version is the PCR test, but several other technologies fall under the molecular testing umbrella.

How Molecular Tests Detect the Virus

All molecular COVID tests work by finding and copying tiny fragments of the virus’s genetic code. The most widely used method, RT-PCR, does this in a precise sequence. First, the viral RNA is converted into DNA through a process called reverse transcription. Then the machine repeatedly heats and cools the sample to separate the DNA strands and make copies of them. Small pieces of synthetic DNA called primers latch onto sequences unique to SARS-CoV-2, ensuring only viral genetic material gets copied. As copying occurs, fluorescent dyes attach to the new DNA strands, producing a glow that signals a positive result.

This copying cycle repeats 20 to 30 times, producing hundreds of copies from even a tiny amount of virus. That amplification step is what makes molecular tests so sensitive. Even if you have a very small amount of virus in your sample, the test can find it.

Other molecular technologies include LAMP (loop-mediated isothermal amplification), which amplifies genetic material at a constant temperature instead of cycling through heat changes. This makes LAMP-based tests faster and easier to run outside a traditional lab, and several have received emergency use authorization from the FDA for home testing.

Types of Samples Used

Molecular tests can be run on several sample types: nasal swabs (from just inside the nostril), nasopharyngeal swabs (deeper, reaching the back of the nasal cavity), throat swabs, sputum, and saliva. Nasopharyngeal swabs have traditionally been considered the gold standard for accuracy, but nasal swabs and saliva collection have become far more common because they’re less uncomfortable and can be self-collected at home. The CDC lists all of these as acceptable specimen types for nucleic acid amplification tests.

How Accurate Molecular Tests Are

Molecular tests are the most reliable COVID tests available. In clinical evaluations, the best-performing RT-PCR tests reached 91 to 94% sensitivity (meaning they correctly identified that percentage of true infections) and 100% specificity (meaning they produced essentially zero false positives). Some older or less optimized test designs showed lower sensitivity, dropping to around 62%, which is why the specific test platform matters.

By comparison, rapid antigen tests are accurate at detecting infections with high viral loads (roughly a million or more viral copies per milliliter), but they miss a meaningful number of infections at lower viral loads. Serological (antibody) tests performed even worse for diagnosing active infection, with sensitivity below 50% in studies.

What the Cycle Threshold Number Means

When a molecular test runs, it produces a number called the cycle threshold, or Ct value. This is the number of amplification cycles the machine needed before it detected enough fluorescent signal to register as positive. The relationship is inverse: a low Ct value (say, under 25) means the machine found virus quickly because there was a lot of it in the sample. A high Ct value (above 25 or 30) means the machine had to work through many cycles to find virus, indicating a lower viral load.

Ct values aren’t typically reported to patients, but they give clinicians useful information. A rising Ct value on repeated tests suggests the infection is resolving and the person is becoming less infectious. A persistently low Ct value suggests a high viral load and greater potential for spreading the virus.

When to Test After Exposure

Timing matters. If you’ve been exposed to someone with COVID but have no symptoms, the CDC recommends testing no earlier than 24 hours after the exposure. If that test is negative, test again 48 hours later (around day 3 after exposure), and if still negative, once more on day 5. This serial testing approach accounts for the fact that the virus needs time to replicate to detectable levels, even for a test as sensitive as PCR.

If you already have symptoms, a single negative molecular test is generally sufficient to rule out COVID in most circumstances. That’s a practical advantage over rapid antigen tests, which often require repeat testing to reach the same level of confidence.

How Long Results Take

This depends on whether you’re using a point-of-care rapid molecular test or sending your sample to a lab. Lab-based PCR tests typically report results in 8 to 16 hours of processing time, though the total wait from sample collection to results can stretch to 24 to 72 hours depending on shipping and lab volume. Rapid molecular tests designed for clinics or home use can deliver results in under 30 minutes because they skip the batching and transport steps.

Molecular Tests and New Variants

One concern with any genetic test is whether viral mutations could cause it to miss new variants. The FDA addressed this by requiring test manufacturers to routinely monitor emerging mutations and report any that could affect performance. Tests that target multiple sections of the viral genome are more resilient to this problem, since a mutation in one target region won’t knock out the others. Single-target tests are more vulnerable to variant-related failures. The FDA’s authorization database flags whether each test uses single or multiple targets, and newer authorized tests from 2024 and 2025 predominantly use multiple-target designs.

Molecular vs. Antigen vs. Antibody Tests

  • Molecular tests detect viral RNA. They’re the most sensitive option and can catch infections earlier, including in people with low viral loads. Results take minutes to hours depending on the platform.
  • Antigen tests detect proteins on the surface of the virus. They’re faster and cheaper but less sensitive, performing best when viral load is high (typically in the first few days of symptoms). A negative antigen test doesn’t rule out infection as confidently as a negative molecular test.
  • Antibody tests detect your immune system’s response to past infection, not the virus itself. They’re not useful for diagnosing an active infection and had sensitivity below 50% when used that way in studies.

For confirming an active COVID infection, especially when symptoms are mild or you’re testing early after exposure, molecular tests remain the most reliable choice. Rapid antigen tests are a reasonable first step for convenience, but a negative result in someone with symptoms or known exposure is stronger grounds for follow-up molecular testing than for assuming the coast is clear.